organization · Reporting owner
Pomona Capital VII, L.P.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NovoCure Ltd
Report date June 23, 2017 · Filed June 27, 2017
Jointly reported with Pomona Capital VII Fund Investors, L.P., Pomona Associates VII, L.P., Pomona Secondary Associates VII LLC, Pomona G.P. Holdings LLC, GRANOFF MICHAEL D, JANIS FRANCES, FUTRELL STEVE
Section 16 reporting ended · disclosed 2017-06-27. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,128,799 |
Reported balance
After 2017-06-23 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2017-06-23 · Sale · Disposed 670,042 · Balance 6,128,799 F1: The transaction was executed in multiple trades at prices ranging from $17.10 to $17.85. The price above reflects the weighted average sales price. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer. F2: The shares are held directly by Pomona Capital VII, L.P. ("PC VII"). The sole member of PC VII is Pomona Associates VII, L.P. ("PCVII GP"). The general partner of PCVII GP is Pomona Secondary Associates VII LLC ("PCVII LLC"). The sole member of PCVII LLC is Pomona G.P. Holdings LLC ("Holdings LLC"). The individual managers of Holdings LLC are Michael D. Granoff ("Granoff"), Frances N. Janis ("Janis") and Stephen M. Futrell ("Futrell") and, as such, each of PCVII GP, PCVII LLC, Holdings LLC, Granoff, Janis and Futrell exercises shared voting and investment power over the shares held of record by PC VII. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of it or his pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | Direct | 2,772,870 |
Reported balance
After 2017-06-23 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2017-06-23 · Sale · Disposed 303,149 · Balance 2,772,870 F1: The transaction was executed in multiple trades at prices ranging from $17.10 to $17.85. The price above reflects the weighted average sales price. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer. F3: The shares are held directly by Pomona Capital VII Fund Investors, L.P. ("PC VII FI"). The Class A general partner of PC VII FI is PCVII GP and the Class B general partner of PC VII FI is PCVII LLC. The general partner of PCVII GP is also PCVII LLC. The sole member of PCVII LLC is Holdings LLC. The individual managers of Holdings LLC are Granoff, Janis and Futrell and, as such, each of PCVII GP, PCVII LLC, Holdings LLC, Granoff, Janis and Futrell exercises shared voting and investment power over the shares held of record by PC VII FI. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | Direct | 6,060,403 |
Reported balance
After 2017-06-26 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2017-06-26 · Sale · Disposed 68,396 · Balance 6,060,403 F4: The transaction was executed in multiple trades at prices ranging from $17.10 to $17.70. The price above reflects the weighted average sales price. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer. F2: The shares are held directly by Pomona Capital VII, L.P. ("PC VII"). The sole member of PC VII is Pomona Associates VII, L.P. ("PCVII GP"). The general partner of PCVII GP is Pomona Secondary Associates VII LLC ("PCVII LLC"). The sole member of PCVII LLC is Pomona G.P. Holdings LLC ("Holdings LLC"). The individual managers of Holdings LLC are Michael D. Granoff ("Granoff"), Frances N. Janis ("Janis") and Stephen M. Futrell ("Futrell") and, as such, each of PCVII GP, PCVII LLC, Holdings LLC, Granoff, Janis and Futrell exercises shared voting and investment power over the shares held of record by PC VII. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of it or his pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | Direct | 2,741,925 |
Reported balance
After 2017-06-26 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2017-06-26 · Sale · Disposed 30,945 · Balance 2,741,925 F4: The transaction was executed in multiple trades at prices ranging from $17.10 to $17.70. The price above reflects the weighted average sales price. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer. F3: The shares are held directly by Pomona Capital VII Fund Investors, L.P. ("PC VII FI"). The Class A general partner of PC VII FI is PCVII GP and the Class B general partner of PC VII FI is PCVII LLC. The general partner of PCVII GP is also PCVII LLC. The sole member of PCVII LLC is Holdings LLC. The individual managers of Holdings LLC are Granoff, Janis and Futrell and, as such, each of PCVII GP, PCVII LLC, Holdings LLC, Granoff, Janis and Futrell exercises shared voting and investment power over the shares held of record by PC VII FI. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: The transaction was executed in multiple trades at prices ranging from $17.10 to $17.85. The price above reflects the weighted average sales price. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.
F2: The shares are held directly by Pomona Capital VII, L.P. ("PC VII"). The sole member of PC VII is Pomona Associates VII, L.P. ("PCVII GP"). The general partner of PCVII GP is Pomona Secondary Associates VII LLC ("PCVII LLC"). The sole member of PCVII LLC is Pomona G.P. Holdings LLC ("Holdings LLC"). The individual managers of Holdings LLC are Michael D. Granoff ("Granoff"), Frances N. Janis ("Janis") and Stephen M. Futrell ("Futrell") and, as such, each of PCVII GP, PCVII LLC, Holdings LLC, Granoff, Janis and Futrell exercises shared voting and investment power over the shares held of record by PC VII. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of it or his pecuniary interest therein, if any.
F3: The shares are held directly by Pomona Capital VII Fund Investors, L.P. ("PC VII FI"). The Class A general partner of PC VII FI is PCVII GP and the Class B general partner of PC VII FI is PCVII LLC. The general partner of PCVII GP is also PCVII LLC. The sole member of PCVII LLC is Holdings LLC. The individual managers of Holdings LLC are Granoff, Janis and Futrell and, as such, each of PCVII GP, PCVII LLC, Holdings LLC, Granoff, Janis and Futrell exercises shared voting and investment power over the shares held of record by PC VII FI. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any.
F4: The transaction was executed in multiple trades at prices ranging from $17.10 to $17.70. The price above reflects the weighted average sales price. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 26, 2017 Filed Jun 27, 2017 16:11 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleCommon Stock | 30,945 | $17.46 | $540,203.77 |
DisclosureSEC source: 0001012975-17-000497 · edgar.xml · nonDerivative · entry 4 Pomona Capital VII, L.P. · CIK 0001701202 · 10% owner Pomona Capital VII Fund Investors, L.P. · CIK 0001701201 · 10% owner Pomona Associates VII, L.P. · CIK 0001701204 · 10% owner Pomona Secondary Associates VII LLC · CIK 0001700911 · 10% owner Pomona G.P. Holdings LLC · CIK 0001700910 · 10% owner GRANOFF MICHAEL D · CIK 0001639347 · 10% owner JANIS FRANCES · CIK 0001639491 · 10% owner FUTRELL STEVE · CIK 0001639633 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,741,925 F4 · price: The transaction was executed in multiple trades at prices ranging from $17.10 to $17.70. The price above reflects the weighted average sales price. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer. F3 · ownership.direct: The shares are held directly by Pomona Capital VII Fund Investors, L.P. ("PC VII FI"). The Class A general partner of PC VII FI is PCVII GP and the Class B general partner of PC VII FI is PCVII LLC. The general partner of PCVII GP is also PCVII LLC. The sole member of PCVII LLC is Holdings LLC. The individual managers of Holdings LLC are Granoff, Janis and Futrell and, as such, each of PCVII GP, PCVII LLC, Holdings LLC, Granoff, Janis and Futrell exercises shared voting and investment power over the shares held of record by PC VII FI. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 16:11 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleCommon Stock | 68,396 | $17.46 | $1,193,982.13 |
DisclosureSEC source: 0001012975-17-000497 · edgar.xml · nonDerivative · entry 3 Pomona Capital VII, L.P. · CIK 0001701202 · 10% owner Pomona Capital VII Fund Investors, L.P. · CIK 0001701201 · 10% owner Pomona Associates VII, L.P. · CIK 0001701204 · 10% owner Pomona Secondary Associates VII LLC · CIK 0001700911 · 10% owner Pomona G.P. Holdings LLC · CIK 0001700910 · 10% owner GRANOFF MICHAEL D · CIK 0001639347 · 10% owner JANIS FRANCES · CIK 0001639491 · 10% owner FUTRELL STEVE · CIK 0001639633 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,060,403 F4 · price: The transaction was executed in multiple trades at prices ranging from $17.10 to $17.70. The price above reflects the weighted average sales price. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer. F2 · ownership.direct: The shares are held directly by Pomona Capital VII, L.P. ("PC VII"). The sole member of PC VII is Pomona Associates VII, L.P. ("PCVII GP"). The general partner of PCVII GP is Pomona Secondary Associates VII LLC ("PCVII LLC"). The sole member of PCVII LLC is Pomona G.P. Holdings LLC ("Holdings LLC"). The individual managers of Holdings LLC are Michael D. Granoff ("Granoff"), Frances N. Janis ("Janis") and Stephen M. Futrell ("Futrell") and, as such, each of PCVII GP, PCVII LLC, Holdings LLC, Granoff, Janis and Futrell exercises shared voting and investment power over the shares held of record by PC VII. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of it or his pecuniary interest therein, if any. Read SEC document |
| June 23, 2017 Filed Jun 27, 2017 16:11 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleCommon Stock | 303,149 | $17.34 | $5,255,906.42 |
DisclosureSEC source: 0001012975-17-000497 · edgar.xml · nonDerivative · entry 2 Pomona Capital VII, L.P. · CIK 0001701202 · 10% owner Pomona Capital VII Fund Investors, L.P. · CIK 0001701201 · 10% owner Pomona Associates VII, L.P. · CIK 0001701204 · 10% owner Pomona Secondary Associates VII LLC · CIK 0001700911 · 10% owner Pomona G.P. Holdings LLC · CIK 0001700910 · 10% owner GRANOFF MICHAEL D · CIK 0001639347 · 10% owner JANIS FRANCES · CIK 0001639491 · 10% owner FUTRELL STEVE · CIK 0001639633 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,772,870 F1 · price: The transaction was executed in multiple trades at prices ranging from $17.10 to $17.85. The price above reflects the weighted average sales price. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer. F3 · ownership.direct: The shares are held directly by Pomona Capital VII Fund Investors, L.P. ("PC VII FI"). The Class A general partner of PC VII FI is PCVII GP and the Class B general partner of PC VII FI is PCVII LLC. The general partner of PCVII GP is also PCVII LLC. The sole member of PCVII LLC is Holdings LLC. The individual managers of Holdings LLC are Granoff, Janis and Futrell and, as such, each of PCVII GP, PCVII LLC, Holdings LLC, Granoff, Janis and Futrell exercises shared voting and investment power over the shares held of record by PC VII FI. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any. Read SEC document |
| June 23, 2017 Filed Jun 27, 2017 16:11 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleCommon Stock | 670,042 | $17.34 | $11,616,987.18 |
DisclosureSEC source: 0001012975-17-000497 · edgar.xml · nonDerivative · entry 1 Pomona Capital VII, L.P. · CIK 0001701202 · 10% owner Pomona Capital VII Fund Investors, L.P. · CIK 0001701201 · 10% owner Pomona Associates VII, L.P. · CIK 0001701204 · 10% owner Pomona Secondary Associates VII LLC · CIK 0001700911 · 10% owner Pomona G.P. Holdings LLC · CIK 0001700910 · 10% owner GRANOFF MICHAEL D · CIK 0001639347 · 10% owner JANIS FRANCES · CIK 0001639491 · 10% owner FUTRELL STEVE · CIK 0001639633 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,128,799 F1 · price: The transaction was executed in multiple trades at prices ranging from $17.10 to $17.85. The price above reflects the weighted average sales price. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer. F2 · ownership.direct: The shares are held directly by Pomona Capital VII, L.P. ("PC VII"). The sole member of PC VII is Pomona Associates VII, L.P. ("PCVII GP"). The general partner of PCVII GP is Pomona Secondary Associates VII LLC ("PCVII LLC"). The sole member of PCVII LLC is Pomona G.P. Holdings LLC ("Holdings LLC"). The individual managers of Holdings LLC are Michael D. Granoff ("Granoff"), Frances N. Janis ("Janis") and Stephen M. Futrell ("Futrell") and, as such, each of PCVII GP, PCVII LLC, Holdings LLC, Granoff, Janis and Futrell exercises shared voting and investment power over the shares held of record by PC VII. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of it or his pecuniary interest therein, if any. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.